Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
QuantLase Lab is an Abu Dhabi-based research and diagnostics company focused on advanced imaging, photonics, and healthcare screening technologies. It became known for developing a laser-based, AI-assisted Diffractive Phase Interferometry (DPI) system for rapid COVID-19 screening, positioned as a mass-screening diagnostic device rather than a therapeutic product. The organization has also described broader work in quantum photonics, quantum biophotonics, and advanced computational research, suggesting activity beyond a single pandemic-era application. QuantLase appears to operate as a private laboratory and innovation center affiliated historically with International Holding Company (IHC). For biotech analysts, the company is best understood as a diagnostics and photonics technology developer in healthcare rather than a traditional therapeutics biotech with a drug pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on QuantLase Lab.